Greece remains in intensive care

Sam Slator 15/07/2015 in Equities, Europe

Whatever the Greek parliament decide to ratify, Greece will remain in intensive care, but for the time being the euro project will carry on regardless. Either Greece accepts the draconian loan requirements or is forced to leave the eurozone altogether.

Either way the remaining 98% of the European economy is little affected. Because of concerns over Greece and the potential contagion effect, European equities have been lagging other western markets so a resolution – of sorts – over Greece could set the scene for a period of catch up. From the very start the other eurozone countries, along with the ECB and the IMF, were determined not to give in to Greek demands for debt forgiveness. They could have weathered that particular storm, had that been allowed to happen, but the same treatment for Portugal, Spain and Italy would have been far too expensive to contemplate. Greece has been sacrificed “pour encourager les autres”.

There are elections in Spain this year, but not until December, so the next edition of “Will they? Won’t they?” is five months off, which gives the markets time to regain some poise. The left wing party Podemos, who have had a rise in fortunes since Syriza in Greece started making headlines, will have taken note of the outcome in Greece as will the Spanish voters. The French presidential elections, where Marine le Pen is currently in the driving seat are not until 2017, but she like an increasing number are calling for a complete reappraisal of the euro project, which she believes is ultimately doomed to failure without total (totalitarian?) political union; not something on her agenda!

So for a tactical foray into Europe we have ten Elite rated funds: BlackRock Continental European, BlackRock Continental European Income, BlackRock European Dynamic, Henderson European Focus and European Special Opportunities, Jupiter European and European Special Situations and Threadneedle European Select. There are also two Elite rated smaller companies funds; Baring Europe Select and T. Rowe Price European Smaller Companies.

This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions. Past performance is not a reliable guide to future returns. Market and exchange-rate movements may cause the value of investments to go down as well as up. Yields will fluctuate and so income from investments is variable and not guaranteed. You may not get back the amount originally invested. Tax treatment depends of your individual circumstances and may be subject to change in the future. If you are unsure about the suitability of any investment you should seek professional advice. Whilst FundCalibre provides product information, guidance and fund research we cannot know which of these products or funds, if any, are suitable for your particular circumstances and must leave that judgement to you. Before you make any investment decision, make sure you’re comfortable and fully understand the risks. Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.